Join FierceBiotech at DIA

Just a quick reminder for everyone who's planning to attend DIA in Boston: I'll be on hand for FiercePharma's Cocktails on the Harbor networking event on Tuesday evening, June 24. Space is limited to RSVP now if you'd like to drop by for cocktails and to meet Tracy Staton, the editor of FiercePharma. We'll also be at DIA that week, so if you'd like to request a meeting, make sure to drop me a line. - John Carroll

Suggested Articles

Zydus Cadila has completed a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 .

A month after scoring $1.6 billion from the U.S. government, Novavax is posting the first human data from its COVID-19 vaccine.

CureVac named a permanent CEO, Franz-Werner Haas, and signed Novartis alum, Igor Splawski, Ph.D. as its new top scientist.